Use the search parameters below to filter talks:

Calendar
Calendar

2012 - TTS International Congress (Berlin)

Preclinical Models of Xenotransplantation
16 July 2012  /  15:30 - 17:00

Primate Recipients of Porcine Livers Develop Fatal Coagulopathy Despite Prevention of Thrombocytopenia

Presenter: Christian Schuetz, ,

- Primate Recipients of Porcine Livers Develop Fatal Coagulopathy Despite Prevention of Thrombocytopenia

Presenter: Christian Schuetz, ,

Expression of Inflammation and Coagulation Genes During GalTKO.hCD46 Xenogenic Lung Perfusion

Presenter: Agnes Azimzadeh, ,

- Expression of Inflammation and Coagulation Genes During GalTKO.hCD46 Xenogenic Lung Perfusion

Presenter: Agnes Azimzadeh, ,

GPIb and GPIIb/ILLa Receptors Regulate Activation and Sequestration of Human Platelets in a Xenogenic Pig Lung Perfusion Model

Presenter: Lars Burdorf, ,

- GPIb and GPIIb/ILLa Receptors Regulate Activation and Sequestration of Human Platelets in a Xenogenic Pig Lung Perfusion Model

Presenter: Lars Burdorf, ,

Beta-Cell Specific Expression of LEA29Y Prevents Cellular Rejection in Islet Xenotransplantation

Presenter: Andrea Baehr, ,

- Beta-Cell Specific Expression of LEA29Y Prevents Cellular Rejection in Islet Xenotransplantation

Presenter: Andrea Baehr, ,

Liver: Indications
16 July 2012  /  15:30 - 17:00

Donor, Candidate, and Center Determinants of Death/Delisting vs. Transplantation and Post-Transplant Outcomes for MELD>30 Waitlist Candidates

Presenter: Sandy Feng, ,

- Donor, Candidate, and Center Determinants of Death/Delisting vs. Transplantation and Post-Transplant Outcomes for MELD>30 Waitlist Candidates

Presenter: Sandy Feng, ,

Predictors of Relapse to Any Alcohol Use After Liver Transplantation: Utility of the Alcohol Relapse Risk Assessment

Presenter: James Rodrigue, ,

- Predictors of Relapse to Any Alcohol Use After Liver Transplantation: Utility of the Alcohol Relapse Risk Assessment

Presenter: James Rodrigue, ,

Five-Year-Experience with High-MELD Recipients (>30 Points) - Single-Centre Results and Re-Evaluation of Prognostic Models for Postoperative Survival

Presenter: Markus Quante, ,

- Five-Year-Experience with High-MELD Recipients (>30 Points) - Single-Centre Results and Re-Evaluation of Prognostic Models for Postoperative Survival

Presenter: Markus Quante, ,

Colorrectal Cancer and Liver Transplant

Presenter: Edurne Alvaro, ,

- Colorrectal Cancer and Liver Transplant

Presenter: Edurne Alvaro, ,

Clinical Course of Inflammatory Bowel Disease in Liver Transplanted PSC Patients: A Nordic Multicenter Study

Presenter: Kristin Kaasen Jørgensen, ,

- Clinical Course of Inflammatory Bowel Disease in Liver Transplanted PSC Patients: A Nordic Multicenter Study

Presenter: Kristin Kaasen Jørgensen, ,

Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer

Presenter: Morten Hagness, ,

- Liver Transplantation for Non-Resectable Liver Metastases from Colorectal Cancer

Presenter: Morten Hagness, ,

Dealing with Sick Liver Transplant Recipients: The Relationship among the MELD Score at Transplantation, Post-Transplant Complications and Resource Consumption

Presenter: Ben-Hur Ferraz Neto, ,

- Dealing with Sick Liver Transplant Recipients: The Relationship among the MELD Score at Transplantation, Post-Transplant Complications and Resource Consumption

Presenter: Ben-Hur Ferraz Neto, ,

Sensitized Patients / AB0 Incomp. in Kidney Transplantation
16 July 2012  /  15:30 - 17:00

No Effect of HLA Antibodies Detected by Luminex Based Single Antigen Tests Only, on Kidney Survival, Graft Function or Acute Rejection

Presenter: Argiris Asderakis, ,

- No Effect of HLA Antibodies Detected by Luminex Based Single Antigen Tests Only, on Kidney Survival, Graft Function or Acute Rejection

Presenter: Argiris Asderakis, ,

5-Years Results of Desensitization Protocol: A Single Center Experience with 36 Patients

Presenter: Eytan Mor, ,

- 5-Years Results of Desensitization Protocol: A Single Center Experience with 36 Patients

Presenter: Eytan Mor, ,

ABO Incompatible (ABOiKTx) Vs Positive Crossmatch Kidney Transplants (+XMKTx): Does Differences in Capillaritis Correlate with Outcome?

Presenter: Andrew Bentall, ,

- ABO Incompatible (ABOiKTx) Vs Positive Crossmatch Kidney Transplants (+XMKTx): Does Differences in Capillaritis Correlate with Outcome?

Presenter: Andrew Bentall, ,

ABO Incompatible Renal Transplantation without Augmented Immunosuppression or Antibody Removal - Report of 10 Cases

Presenter: Nicholas Torpey, ,

- ABO Incompatible Renal Transplantation without Augmented Immunosuppression or Antibody Removal - Report of 10 Cases

Presenter: Nicholas Torpey, ,

Complement Inhibition with Eculizumab to Prevent Antibody Mediated Rejection (AbMR) in Patients with Donor Specific Anti-HLA Antibody (DSAb) and a Positive Cross Match

Presenter: Shlomo Cohney, ,

- Complement Inhibition with Eculizumab to Prevent Antibody Mediated Rejection (AbMR) in Patients with Donor Specific Anti-HLA Antibody (DSAb) and a Positive Cross Match

Presenter: Shlomo Cohney, ,

Impact of Different Levels of Preformed Anti-HLA Donor Specific Antibodies Detected by Single Antigen Luminex Assay on Kidney Transplants Performed with Negative Complement Dependent Cytotoxicity T and B Crossmatches

Presenter: Alexandre Holanda Cavalcanti, ,

- Impact of Different Levels of Preformed Anti-HLA Donor Specific Antibodies Detected by Single Antigen Luminex Assay on Kidney Transplants Performed with Negative Complement Dependent Cytotoxicity T and B Crossmatches

Presenter: Alexandre Holanda Cavalcanti, ,

Late Breaking Abstracts - Kidney
16 July 2012  /  15:30 - 17:00

CMV Valganciclovir Prophylaxis Versus Preemptive Therapy after Renal Transplantation: Three Year Results of a Randomized Clinical Trial

Presenter: Ingeborg Hauser, ,

- CMV Valganciclovir Prophylaxis Versus Preemptive Therapy after Renal Transplantation: Three Year Results of a Randomized Clinical Trial

Presenter: Ingeborg Hauser, ,

An International Analysis of Policy Shifts to Donation After Cardio-circulatory Death (DCD) and Their Effect on Deceased Organ Donation and Transplantation Rates

Presenter: Aric Bendorf, ,

- An International Analysis of Policy Shifts to Donation After Cardio-circulatory Death (DCD) and Their Effect on Deceased Organ Donation and Transplantation Rates

Presenter: Aric Bendorf, ,

Angiotensin II Blockade in Kidney Transplant Recipients: A Primary Prevention Trial

Presenter: Hassan Ibrahim, ,

- Angiotensin II Blockade in Kidney Transplant Recipients: A Primary Prevention Trial

Presenter: Hassan Ibrahim, ,

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi